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Ten patients with moderate to severe atopic dermatitis 
had increased levels of IgE in the blood and a reduced 
level of T cells with Fc receptors for IgG (T,). After 
pronase and trypsin digestion of Fc receptors, cultured 
T cells regenerated the Fc receptors, but preserved the 
difference between patients and controls. Neuramini-
dase treatment increased the T y-cell level in both pa-
tients and controls. Serum from patients with atopic 
dermatitis could not reduce the T y-cell expression in the 
controls. With r egard to Fc receptors, no qualitative 
difference was observed between patients and controls, 
but a genuine quantitative difference accounts for the 
observed r eduction of T y cells in blood. 
Patients with atopic derma titis frequently h ave increased IgE 
a n t ibody in serum a nd red uced ~ell-med iated immune reactivity 
(for a r eview, see [IJ). These ch a nges may be interrelated, 
because experime n ts in rats and mice have demonstrated that 
th e IgE syn t h esis is influe nced by T cells [2-5]. Probably both 
T -helper a nd T-suppressor cells exist for IgE synth esis, but t h e 
phenotypes of t h ese cells a r e still unknown. 
In huma ns, T -suppressor a nd T-helper cells have been found 
to carry Fc receptors for IgG (T y ceUs) or IgM (T
" 
cells) [6-8]. 
These phenotypes give no definitive description of cell functions 
[9-11]. However, t he finding of a red uced level of T y cells a nd 
a depressed no nspecific suppressor cell activity in patie nts with 
atopic de rmatitis may be related to t h e increased IgE level in 
blood [12-14]. 
This paper attempts to determine the cause of the reduced 
level of T y cells in patie nts w ith atopic dermatitis . The results 
indicate no defective r eceptor expression, but a genuine loss of 
circu lating T y cells. 
PATIENTS AND METHODS 
Ten patient.s, 7 females and 3 males, with modera te to seve re atopic 
dermatitis were studied. Some patient.s also had rhini t is and asthma. 
T he il' age range was 17-45 years, mea n 28.9 years. Five patients had a 
severe genera li;:ed atupic ec;:ema and 5 pat ient.s had minima l cl inica l 
disease activ ity and loca liwd atop ic ec;:e ma. T hree patients had a 
normal 19E level in blood and 7 patients had elevated levels or IgE, 
range 679-39,000 IV/ m/. mean 11,567 IV/ m!. Patients were t reated 
with topical sleroids only. From lhe venereal cl inic 10 individuals 
without actual disease se;'ved a' controls, 6 fema les and 4 males, age 
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range 21-36 years, mean 26.9 years. The control had neither family 
history of' atopic conditions nor s igns of atopic dermatitis. 
Isolation of Lymphocytes 
Ten millilit ers of heparinized blood (20 IV pel' ml of heparin) and 10 
ml serum were obtained in the morning. Phagocytic ce lls were rcmoved 
by adding 0.2% carbonyl iron to the blood, a nd lymphocytes were 
isolated by Ficoll-Hypaque flotation. Aft.er separation the cells were 
washed 3 times in Hanks' balancecl sa lt solu tion (HBSS) with 2.5% fetal 
calf serulll (FCS) and adj usted t.o 1 x iOn ce lls/ m!' 
Purifica/ion of T Cells 
The method of AET(2-aminoethyli50thiOUl'onium bromide hydro-
bromide)- t reated sheep red cells was llsed for T-cell purification [13]. 
Preparalion of Anli-Ox An.tibodies 
A detailed description has been given previously [13]. 
t;ry lhrocyte-Antibody (EA) Suspensions 
Ox red blood ce ll (ORBC)-ant ibody complexes were prepared from 
ox erythrocytes in Alsever's so lution, washed 5 limes in HBSS and 
resuspended to a concenlra tion of 2%. Subagglu tinat ing concentrations 
of IgG or IgM a nt ibody were mixed with eq ua l volu mes of 2% ORBC 
and kept. for 90 min at room temperature. Three wa hes of the ORBC-
antibody co mplexes were done in HBSS wit.h 2.5% FCS. Fina lly, 10% 
FCS was added. These EA suspensions were kept at 4°C a nd used 
dlll'ing the ncxt 2 days. 
Purilication ol T-Cell S lIbpoplilations 
One mi ll iliter of purified l' cells (1 X 10'/ ml) was mixed wit.h an 
eq ua l volume of ORRC coated with either IgG or IgM antibody in 
HBSS with 2.5"f, FCS in a ratio of 1 :100. The mixt ures were centrifu-
gat.ed immediate ly at 150 g for 5 min and incubated at 4°C for 60 min. 
Afl er gentle resuspension, Ficoll-Hypaquc fl ot.ation was performed (800 
g for 15 min). In t.he ce ll pell ets the number of rose tting cells was 
determined a fter gentle resuspension. The purit.y of T y cells was 82.0'i~ 
(range 75-89%) a nd T ,. ce lls 76.5% (range 69-81 %). The pellets of' 
posit.ively selccted T y cells or 1'" cclls were resLl spended in 0.83% Tri5-
NH,CI 1'01' lysis of OHBC (10 min). Negatively selected T y cells 01' '1'" 
ce lls were obta ined from the nonl'oseUi ng cells in the intermediate 
laye r of Fico ll -Hypaq ue grad ients of T -ce ll mixtures with EA'.M 01' 
EA,." . respect ively. T cells from the pelle ts and the int.ermedia te layers 
wcre washed 3 times with HBS. without. seru m. Purified cell popula-
t.ions were adjusted t.o I X 10'; ce lls/ ml in RPM! 1640 with 20% FCS 
penicillin (100 I'/ ml), streptomycin ( 100 I<g/ ml) . and gentamycin (1.5 
J.lg/ ml) and incubat.ed at 37°C in a humidified 5c;, CO" atmosphere. 
1~lIl11l1eratiol1 of T-Cell SlIbpoplllatiol1s 
T cells cu ltured overnight. in RPM! 1640 with 20% FCS, penicillin 
(100 I'/ m\) , s treptomycin (100 I'g/ ml), and gentamycin (1.5 J.lg/ ml) were 
washed 3 Limes with HBSS with 2.5% FCS and adj usted to I x 10'; 
ce lls/ml. T cells (0.01 ml) were mixed with ORBC coated with eithcr 
IgG (0.0 1 ml) 01' IgM (0.01 ml) at a 'I' ce ll: EA ra tio of 1:100, spun 
immediately at 150 g for 5 min a nd incubated at 4°C fo r 3 hI'. Aft c r 
addition of 5 ~d of 0.1 % acridine-orange, th e pellet was car efully resus-
pended by 2 gentle rollings of the tubes between t he palms and 200 T 
cells were count ed in a f1uol'escence microscope. 'I' cells with 3 or more 
er.vth rocytes bound t.o their su rface were counted as rosette-forming 
ce lls. 
En zymatic Treatment of T Cell" 
T cells cultured fo r 24 hI' were washed oncc and resuspended a t. I X 
to'; ce ils/ illi in HBSS without serum (medium cont.rol) or Pronase 
(prot.ease, S igma, Type XIV). trypsin (Sigma, Type III) , or neuramin -
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idase (Sigma, T ype V) . The cells were incubated at 37°C for 30 min 
and then washed 3 t imes with HBSS with 2.5% FCS and adjusted to 1 
X lO/;/ ml for rosette enumeration (day 1). The enzyme- treated cells and 
control cells were resuspended in RPMI 1640 with 20% FCS, penicillin 
(100 I' / ml), streptomycin (100 I'g/ ml), and gentamycin (1.5I'g/m l ) and 
cul tUJ"ed overnight in a humidified 5% CO" atmosphere for reexpression 
of Fc receptors. At day 2 the cells were washed 3 t imes with HBSS 
with 2.50/, FCS and adjusted to 1 X 101i/ ml before roselle enumeration. 
Viability was greater than 90% except for neuraminidase 50 I' / ml (50%) 
and 10 /ll ml (60%) as assessed by trypan blue dye exclusion. 
Serum Assays 
T cells from healt hy persons were cul tured for 48 hr before incubation 
for 60 min at 37°C with autologous or atopic serum where immuno-
globulins were either present or removed by ammonium sulfate precip-
ita tion. Medium controls were T cells withou t serum. Serum was not 
heat inactivated. Cell numbers and cell deaths were recorded and were 
found to be unaffected by the treatment of serum with or without 
immunoglobu lins (viable cells> 98%). Three washes with HBSS with 
2.5% FCS were done before rosette enumeration. 
RESULTS 
We confirmed our previous findings of a s ignificantly reduced 
pe rcentage of T y cells in blood from patients with atopic d e r-
matitis (Table I). Likewise, we did not find any correlation 
between the IgE levels in serum and the percentage of T y cells 
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on day 1 (r" = 0.1708) or between the severity of the disease 
a nd t h e percentage of T y cells (r2 = 0.1560). 
When prote in was partly removed {i'om the cell s urface 
through pronase treatment, both Fc-IgG and Fc-IgM receptors 
disappeared but reoccurred after 24 hr of culture. Trypsin 
treatment affected only t h e Fc-IgM receptors (Table I). Neur-
aminidase treatment, which reduces the cell sUTface charge, 
in creased the percentage ofTy cells a nd reduced the percentage 
of T " cells (Table I). This indicates that some T cells without 
Fc-IgG or Fc-IgM receptors actually have F c-IgG r eceptors on 
their sUTface, but do not express t hem under ordinary condi-
tions. However, in a ll enzyme studies patients with atopic 
dermatitis still h ad reduced T y-cellieveis. 
When serum from patients with atopic dermatitis and in-
creased amounts of IgE in serum was added to T cells from 
con t rols, no reduction occurred in t he percentage of T y cells 
Cfable II). Thus, blocking immune complexes could not be 
detected. T y cells positively selected by rosette formation with 
EA-IgG immune complexes lost their ability to express Fc-IgG 
receptors. Fc-IgM receptors co uld be detected on thes e cells, 
although it cannot be excluded that this may represent an 
increase in Fc-IgM receptors of T" cells eventually contaminat-
ing t h e T y-cell popu lation (Table III) . N egative ly selected T y 
cells (i.e. , nonrosetting cells from the in termediate layers of 
Ficoll -Hypaq ue gradients of T-cell mixtures with EAI~M) h ad a 
normal Fc-IgG receptor expression (data not shown) . 
TABLE I. Effect of pronase, tl yp sin, and neurCtlninidase on T y and T" cells in patients with atopic dermatitis and cont.rols 
Day 'I Day 2 
Atopic derma t. itis Conlrols Alopic dermalilis Conlrols 
'f y% 1",,% 'l\ % '] '/1 %; T'y% 1',.% 1" 01 'f,,% y'O (runge) (range) (range) (range) (range) (range) (range) (range) 
M edium 6.5" ,01 ;1:3.4 12,7 24 .4 7.3"'" 50.4 11.8 45.7 
(2- 15) (12-5 1) (8- 19) (1 5-:17) (J -17) (38-66) (8- 16) (30-55) 
A . Pronase 
(I'g/ ml) 
1200 O",t! 0'1,11 0"'" 0"' " 7.2 52.6 11.7 47.0 
(0) (0) (0) (0) (3-16) (39-65) (8-20) (29-62) 
600 5.3 0" '" 9.2 Oh, II 8.0 52.2 12.6 47.5 
(3-12) (0) (3-16) (0) (1-20) (38-63) (8-23) (35-65) 
300 6. 1 0"' " 11.4, 0'" " 7.9 52.5 12.9 47.6 
(3-11) (0) (1-18) (0) (2-20) (40-65) (9-24) (35-65) 
150 6.7 0"'(/ 12.3 0"'" 5.6 52.9 13.7 47.8 
(4-12) (0) (7-18) (0) (2-14) (42-65) 00-25) (30-62) 
75 6.4 2.6'1. II 13.0 2.1'" " 7.4 51.7 12.0 48.3 
(4-14) (0-16) (8-19) (0-18) (2-19) (31-67) (7-8) (39-62) 
37.5 6. l G.6 "·oJ 12.4 5.3"'" 7.3 50.5 12.3 47.3 
(3-14) (0-17) (9-18) (2-20) (2-19) (40-60) (6-25) (39-67) 
B. Tlypsin 
(I'g / ml) 
0'"·,, 5000 7.G 14.3 0"'" 9.4 50.6 10.7 43.5 
(3-13) (0) (9-21) (0) (2-19) (35-70) (8-]7) (30-60) 
1000 6.2 0.9" ' " 12.8 0.7 "'" 7.6 50.5 10.0 43.4 
(3-12) (0-7) (8-18) (0- 4) (2-17) (40-68) (5-16) (28-58) 
50 7.2 10.2'" 01 13.1 8.0,,· 01 7.4 48.7 11.0 45.5 
(2-11) (2-27) (8-18) (2-22) (2-16) (39-66) (6-21) (33-60) 
C. Neuraminidase 
(1'/ ml) 
50 11.3"' " 0'" " 19.0"' " 0'" " 5.2 O",d 11.8 Ofl,r! 
(4-19) (0) (14-26) (0) (1-14) (0) (5-18) (0) 
10 12.7"'" 0"'" 18.8'" 01 0"'" 6.9 19.2'" " 10.1 20.2 "'" 
(5-30) (0) (15-25) (0) (1- 17) (3-43) (6-16) (9-25) 
11 .5/1, II 10.7'" d 17.6'" d 10.8"'" 6.9 40.5 12.8 43.1 
(4-30) (0-31) (14-24) (0-21) (2-15) (18-65) (7-31) (26-64) 
0.1 7.2 30.8 13.7 22.9 6.2 51.4 11.3 44.8 
(3-10) (1 8-50) (9-20) (13-46) (2-17) (36-69) (6-24) (30-68) 
T cells from 10 patients with atop ic dermatitis and 10 contro ls were cultured for 24 hr (day 1), incubated with pronase (A), t rypsin (B) , or 
neuraminidase ( C ) at 37°C for 30 min, and washed 3 times before rosette enumerations. After overnight cu lture of enzyme-treated ce lls in RPM! 
1640 with 20% FCS, rosette enumerations were repeated (day 2). 
" Medium values of patients vs. controls (Mann-W hitney test). 
" Values of enzyme-treated cells vs. medium values (Wilcoxon text). 
' p < 0.05. 
"p < 0.0t. 
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TABLE II. Effect of serum from patients with atopic dermatitis on Ty 
and T" p ercentage in control persons 
Medium 
Autologous serum 50% 
Autologous serum 50% without Ig 
Atopic dermatit is serum 50% 
Atopic dermatitis serum 50% with-
outIg 
Ty% (range) 
11.7 (8-16) 
11.2 (4- 16) 
10.3 (5-15) 
9.6 (2-16) 
11.6 (5-16) 
1',.% (range) 
44.6 (30-47) 
48.8 (36-51) 
42.8 (32-46) 
38.0 (28-43) 
42.9 (20-43) 
T y and 1'" percentages in 9 controls. l' cells were cul tured for 48 hI', 
incubated with 50% serum for 60 min at 37°C, and washed 3 times with 
HBSS and 2.5% FCS, before rosette enumerations. Serum included 
autologous serum with and without immunoglobulins (Ig) and serum 
f1'om 9 patients with atopic dermatit is with and without Ig. 
TABLE III. Expression of Fc·lgG and Fc-IgM receptors on positively 
selected Ty cells 
Tcells Cu ltUl'e of positively selected T, cells 
'1' % T l'% '1' /J6 '1',,% '1',,% 01,1' 24 hI' 48 hI' 24 hI' 48 hI' 
1. Control person 20 0 0 5 18 
2. Control person 12 1 0 10 20 
3. Atopic dermatitis 5 0 0 11 23 
4. Atopic dermatitis 3 1 0 12 19 
T y cells purified through EA-IgG rosetting (see Patients and 
Methods). The T y-cell percentage was determined before separation 
(0 hr). Purified T y cells were investigated for Fc-IgG and Fc-IgM 
receptors on T y cells cultUl'ed for 24 and 48 hr. 
DISCUSSION 
Several studies have now confirmed the observation of a 
reduced percentage of Ty cells in blood from patients wit h 
atopic dermatitis (Table I) [12-14]. Pronase a nd trypsin diges-
t ion of t h e Fc-receptor glycoproteins on t he T cells did not 
reveal a reversibly blocked Fc-IgG receptor expression in pa-
tients with atopic dermatitis. Following proteolysis th e recep-
tors were regenerated to t he level of untreated cells, but the 
percentage of T y cells was still s ignificantly reduced. The 
reexpression of the Fc receptors depends upon de novo protein 
synthesis [15-16], so, the individual T cell in atopic patients 
reacts normally in regal'd to receptor synth esis. This was also 
supported by the r esults from neUl'aminidase treatment, which 
increased th e percentage of T y cells, but preserved t h e differ-
ence between patients with atopic dermatitis and h ealth y con-
trols, suggesting that t he decrease in T y cells in atopic dermatitis 
is not a mere excess of T cells t hat are not expressing Fc-
receptors. Thus, regarding Fc receptors we have been unable to 
find qualitative defects of t h e T-cell surface membrane in atopic 
dermatitis. 
Addition of serum from patients wit h atopic d ermatitis to T 
cells from healt hy con trols did not reduce t h ei.r Fc-IgG expres-
s ion, which gives no indication of in vivo ilnrTIUne complex 
blocking of t h e Fc-IgG receptor in patients with atopic derma-
titis. The in vit ro blocking by i.mmune complexes thl'ough 
rosette purification of T cells [10] was equal in patients and 
controls (Table III). 
This study emphasizes t hat a genu ine quantitative difference 
exists in th e T y-cell percentage between patients with atopic 
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dermatit is and healthy controls. T his may be due to a deficit of 
T cells [13] 01' to an a ltered T-cell distribution with accumula-
tion of T y cells, e.g., in th e spleen. Thus, redistribution of T cells 
may expla in t h e increased T y-cell percentage observed in atopic 
patients following hyposensitization [17]. 
It remains unsettled whether t he reduction of the T y-cell 
population bears any relationship to the increased IgE synthesis 
in patients with atopic dermatitis. T h e r educed nonspecific 
suppressor cell activity in patien ts [13-14] could be related [5] 
to such a change. 
We want to thank Mrs. A. Jespersen and J. Schj~th for technical 
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